Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007342
Chunk: 20

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 20
---
 indirectly, any “short sale” (as such term is defined in Rule 200 of Regulation SHO
of the Exchange Act) of our Depositary Shares.

Effect of Sales of our Depositary Shares under the Purchase Agreement on our Shareholders

The Depositary Shares being
registered for resale in this offering may be issued and sold by us to the Selling Shareholder from time to time at our discretion, during
the terms described above. The resale by the Selling Shareholder of a significant quantity of shares registered for resale in this offering
at any given time, or the perception that these sales may occur, could cause the market price of our Depositary Shares to decline and
to be highly volatile. Sales of our Depositary Shares, if any, to the Selling Shareholder under the Purchase Agreement will be determined
by us in our sole discretion, subject to the satisfaction of certain conditions in the Purchase Agreement, and will depend upon market
conditions and other factors. We may ultimately decide to sell to the Selling Shareholder all, some or none of the Depositary Shares that
may be available for us to sell to the Selling Shareholder pursuant to the Purchase Agreement. If we elect to sell Depositary Shares to
the Selling Shareholder pursuant to the Purchase Agreement, after the Selling Shareholder has acquired such shares, the Selling Shareholder
may resell all, some or none of such Depositary Shares at any time or from time to time in its discretion and at different prices. As
a result, investors who purchase Depositary Shares from the Selling Shareholder in this offering at different times will likely pay different
prices for those shares of Depositary Shares, and so may experience different levels of dilution and in some cases substantial dilution
and different outcomes in their investment results. See “Risk Factors-Risks Related to the Committed Equity Financings-Investors who buy Depositary Shares from the Selling Shareholder at different times will likely pay different prices.”

Investors may experience a
decline in the value of the Depositary Shares they purchase from the Selling Shareholder in this offering as a result of future sales
made by us to the Selling Shareholder at prices lower than the prices such investors paid for their shares in this offering. In addition,
if we sell a substantial number of Depositary Shares to the Selling Shareholder under the Purchase Agreement, or if investors expect that
we will do so, the actual sales of Depositary Shares or the mere existence of our arrangement with the Selling Shareholder may make it